{
  "docId": "019de076-c164-739c-925e-e97b24983f20",
  "docSlug": "45699c5d62cd10656fd74cee2718d284",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 35,
  "pageCount": 45,
  "prevPage": 34,
  "nextPage": 36,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The slide uses a grid layout to categorize clinical trials by disease stage and molecular profile, highlighting established standards of care.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-c164-739c-925e-e97b24983f20/35",
  "deckHref": "/decks/019de076-c164-739c-925e-e97b24983f20",
  "deckJsonHref": "/decks/019de076-c164-739c-925e-e97b24983f20.json",
  "deckAnchorHref": "/decks/019de076-c164-739c-925e-e97b24983f20#slide-35",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.22,
        "x": 0.75,
        "y": 0.22
      },
      "kind": "list",
      "text": "Leading the future of lung cancer treatment: Establishing Tagrisso, Imfinzi, ADCs, bispecifics, and novel combinations.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a1c1136f-2a38-4404-9b31-3a763584c6cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Collaboration partners: Daiichi Sankyo (Enhertu, Dato-DXd), Compugen (rilvegestomig). Appendix: Glossary.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59ea7514-b87f-4804-bcc7-5d8d71e9ed44",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.71,
        "x": 0.03,
        "y": 0.22
      },
      "kind": "table",
      "text": "Matrix of clinical trials by stage (resectable, unresectable, metastatic) and tumor driver (IO sensitive, EGFRm, etc.)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12eed9c1-e881-468d-a5cc-62d0f37b430c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.8,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Ambition for >50% of lung cancer patients to be eligible for AZN medicine by 2030",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3130d178-64a1-441d-99cb-a3c95d3e6622",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "AstraZeneca in Lung Cancer",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e936247-f562-4fde-a244-dffa4664ebd3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "a02caf28-e8a4-40ed-9f8e-e6c09aba59f4",
      "evidence": "Matrix of clinical trials by stage (resectable, unresectable, metastatic) and tumor driver (IO sensitive, EGFRm, etc.)",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "matrix-nxn",
      "slug": null,
      "matchId": "43905f0a-af1d-4a3c-875f-4a9eb947c0e4",
      "evidence": "The slide organizes clinical trials into a grid based on disease stage and tumor driver.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}